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A site-directed mutation in motif IV of Escherichia
coli DNA helicase II (UvrD) was generated to examine
the functional significance of this region. The highly
conserved arginine at position 284 was replaced with
alanine to construct UvrD-R284A. The ability of the mu-
tant allele to function in methyl-directed mismatch re-
pair and UvrABC-mediated nucleotide excision repair
was examined by genetic complementation assays. The
R284A substitution abolished function in both DNA re-
pair pathways. To identify the biochemical defects re-
sponsible for the loss of biological function, UvrD-R284A
was purified to apparent homogeneity, and its biochem-
ical properties were compared with wild-type UvrD.
UvrD-R284A failed to unwind a 92-base pair duplex re-
gion and was severely compromised in unwinding a 20-
base pair duplex region. The Km of UvrD-R284A for ATP
was significantly greater than 3 mM compared with 80
mM for UvrD. A large decrease in ATP binding was con-
firmed using a nitrocellulose filter binding assay. These
data suggested that the R284A mutation severely re-
duced the affinity of helicase II for ATP. The reduced
unwinding activity and loss of biological function of
UvrD-R284A was probably the result of decreased affin-
ity for ATP. These results implicate motif IV of super-
family I helicases in nucleotide binding and represent
the first characterization of a helicase mutation outside
motifs I and II that severely impacted the Km for ATP.
Helicase-catalyzed unwinding of double-stranded nucleic
acid molecules is required in all aspects of DNA and RNA
metabolism including replication, DNA repair, recombination,
transcription, translation, RNA processing, and bacterial con-
jugation (1–10). Helicases couple the energy derived from hy-
drolysis of nucleoside 59-triphosphates (NTPs)1 to the disrup-
tion of hydrogen bonds between the complementary bases of a
double helix. The mechanism of unwinding is not known al-
though models have been proposed and are currently being
tested (7, 11, 12). These models are based on the formation of
active oligomers, which provide multiple DNA binding sites for
the helicase. Most, if not all, helicases appear capable of form-
ing either a dimer or hexamer, and evidence suggests that the
oligomer is an active species (7).
Helicases are ubiquitous in nature, with numerous examples
in viral, prokaryotic, and eukaryotic organisms. Extensive com-
puter-assisted sequence analysis of numerous helicases has
uncovered a series of short, conserved amino acid motifs (13–
15). This has allowed grouping of helicases into four families
based on the extent of amino acid similarity and on the orga-
nization of these conserved regions. These families presumably
represent evolutionary relationships. Superfamilies I and II
are the largest and most closely related groups, whereas su-
perfamily III and family IV have unique motif compositions
that differ considerably from those in superfamilies I and II
and from each other (16).
Analysis of helicases with mutations in highly conserved
residues in several of the so-called “helicase motifs” has sug-
gested a biochemical role of some of these regions in helicase
function. For example, motifs I and II, first described as the
Walker A and B sequences in a large family of NTP binding
proteins (17), have been directly implicated in NTP binding
and/or hydrolysis (18–22). The function of the remaining heli-
case motifs is less clear. Roles for motif VI in nucleic acid
binding and ATP hydrolysis have been proposed for various
superfamily II RNA helicases (23–25). Motif V has been impli-
cated in single-stranded DNA (ssDNA) binding (26) and motif
III in coordination of ATP and ssDNA binding (27) for super-
family I helicases. The recent crystal structure of PcrA, a su-
perfamily I DNA helicase from Bacillus stearothermophilus,
suggested that all seven of the conserved helicase motifs are
clustered together in the vicinity of the ATP binding site (28).
Thus, all of the motifs may be involved in ATP binding and/or
hydrolysis, at least for those enzymes with structures similar to
PcrA.
Escherichia coli DNA helicase II, the product of the uvrD
gene, is a well characterized DNA helicase. This enzyme is a
required component of the UvrABC-mediated nucleotide exci-
sion repair pathway (29, 30) and the methyl-directed mismatch
repair pathway (31). Less defined roles in recombination and
DNA replication have also been suggested (18, 19, 32–40). The
purified enzyme unwinds DNA with 39 to 59 polarity (41) and is
capable of initiating unwinding from a nick, its presumed bio-
logical substrate in the repair pathways (42–44). UvrD belongs
to helicase superfamily I along with other E. coli helicases such
as Rep, RecB, RecD, TraI, and helicase IV (helD gene product)
(13, 16), as well as a large number of eukaryotic viral helicases
and several yeast helicases.
UvrD has previously been the subject of biochemical and
genetic studies involving mutation of highly conserved residues
in motifs I, II, and III (18, 19, 27, 44). Currently, very little
biochemical information exists on the specific role of motif IV in
superfamily I and II helicases although its importance for
biological function has been demonstrated in genetic studies
(45–47). In this report, the functional significance of motif IV in
E. coli DNA helicase II was addressed by site-directed mu-
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tagenesis of arginine residue 284, which is invariant among
superfamily I helicases. The results indicated that the mutant
protein had a significant decrease in affinity for ATP, implicat-
ing motif IV in nucleotide binding. This represents the first
helicase mutation outside of motifs I and II that exhibits a
severe defect in nucleotide binding.
EXPERIMENTAL PROCEDURES
Materials
Bacterial Strains—E. coli BL21(DE3) (F2 ompT [lon] hsdSB rB
2 mB
2
gal dcm lDE3) was from Novagen, Inc. E. coli JH137 (K91 lacZ
dinD1::MudI (Apr lac)) was obtained from Dr. P. Model (Rockefeller
University). BL21(DE3)DuvrD and JH137DuvrD were constructed pre-
viously in this laboratory (18).
DNA and Nucleotides—pET81F11 was from Dr. P. J. Laipis (Uni-
versity of Florida), and pET9d, pET11d, and pLysS were from Novagen,
Inc. M13mp7 ssDNA was prepared as described previously (48). Unla-
beled nucleotides were from U. S. Biochemicals Corp. Radioactively
labeled nucleotides were from Amersham Corp. pET9d-UvrD and
pET11d-UvrD were constructed previously in this laboratory (18).
Enzymes—Restriction endonucleases, DNA polymerase I (large frag-
ment), phage T4 DNA ligase, phage T7 DNA polymerase, and phage T7
polynucleotide kinase were from New England Biolabs Inc. and used as
recommended by the supplier.
To overexpress helicase II prior to purification, a 10-liter culture of
mid-log phase BL21(DE3)/pLysS cells containing pET11d-UvrD or a
2-liter culture of mid-log phase BL21(DE3)DuvrD/pLysS cells contain-
ing pET9d-UvrD-R284A were induced for protein expression by adding
isopropyl b-D-thiogalactopyranoside to 0.5 mM. Growth was continued
for 4 h at 37 °C. Wild-type and mutant helicase II proteins were purified
using a procedure described previously (49). The concentration of puri-
fied protein was determined by spectrophotometric absorbance read-
ings at 280 nm using the previously published helicase II extinction
coefficient of 1.29 ml mg21 cm21 (49). Storage buffer for helicase II was
20 mM Tris-HCl (pH 8.3), 200 mM NaCl, 25 mM 2-mercaptoethanol, 1
mM EDTA, 0.5 mM EGTA, and 50% glycerol.
Methods
Site-directed Mutagenesis—The plasmid pET81F1-UvrD (27), con-
taining the full-length helicase II coding sequence cloned behind a T7
promoter, as well as the phage F1 origin of replication, was the template
for site-directed mutagenesis by standard procedures (50). The oligonu-
cleotide 59-GCTGGTAGAGGCGTAGTTTTGCTCC-39 altered codon 284
of helicase II from CGC(arginine) to GCC(alanine) and disrupted a
BsrBI restriction site, allowing the initial screening of mutants by
restriction digest. After mutagenesis, a 2.0-kilobase pair NcoI-BsiWI
DNA fragment containing the desired mutation was sub-cloned into
pET9d-UvrD, replacing the wild-type NcoI-BsiWI fragment in this plas-
mid and generating pET9d-UvrD-R284A. The presence of a single mu-
tation at the correct location was verified by sequence analysis of the
entire helicase II gene in pET9d-UvrD-R284A using an Applied Biosys-
tems 373A DNA Sequencer.
Genetic Assays—UV irradiation survival was determined as de-
scribed (19). The frequency of spontaneous mutant formation was de-
termined as follows. Eleven independent transformants of each of the
appropriate cell strains were grown overnight under antibiotic selection
at 37 °C. Serial dilutions of each of the saturated cultures were made in
M9 minimal media salts. Appropriate dilutions were plated on LB agar
to determine cell titer and on LB agar plus 100 mg/ml rifampicin to
determine the number of spontaneously arising rifampicin-resistant
cells. After incubation at 37 °C for at least 24 h, colonies were counted,
and the spontaneous mutant frequency was calculated for each strain
by dividing the median value of rifampicin-resistant cells by the aver-
age total viable cells.
Proteolytic Digestion—Limited chymotrypsin cleavage of UvrD and
UvrD-R284A was performed as described previously (51). a-Chymo-
trypsin (5 ng) was added to reactions (15 ml) containing either 2 mM
UvrD (monomer) or 1.8 mM UvrD-R284A (monomer), and the reaction
was incubated for 2 min at room temperature (25 °C). Where indicated,
2 mM M13mp7 ssDNA was included. Reactions were stopped with 15 ml
of gel loading buffer (250 mM Tris-HCl (pH 6.8), 3.4% SDS, 1.1 M
2-mercaptoethanol, 20% glycerol, 0.01% bromphenol blue) and boiled
for 2 min. Products were resolved on a 12% polyacrylamide gel (32:1
cross-linking ratio) in the presence of 0.1% SDS and visualized by
staining with Coomassie Brilliant Blue R-250 (Sigma).
Nitrocellulose Filter Binding Assays—The binding of UvrD and
UvrD-R284A to ssDNA was determined by measuring the retention of
[32P]DNA on nitrocellulose filters as described previously (52). Reac-
tions (20 ml) contained 25 mM Tris-HCl (pH 7.5), 3 mM MgCl2, 20 mM
NaCl, 5 mM 2-mercaptoethanol, 50 mg/ml bovine serum albumin, and a
[32P]-labeled 92-bp partial duplex helicase substrate (approximately 1.3
mM nucleotide phosphate) (1.86 3 108 cpm mmol21). Binding reactions
were initiated with UvrD or UvrD-R284A over a concentration range of
0.7–84 nM (monomer). After incubation at 37 °C for 10 min, 1 ml of
reaction buffer (pre-warmed at 37 °C) was mixed with each sample, and
the entire volume was passed through a nitrocellulose filter at a flow
rate of 4 ml/min. Filters were washed twice with 1 ml of pre-warmed
reaction buffer, dried, and subjected to liquid scintillation counting.
Background binding in the absence of enzyme represented less than
0.5% of the total signal and was subtracted from the experimental data.
Apparent Kd values were calculated as described previously (27, 53).
Binding of [3H]ATP to UvrD was also examined by nitrocellulose
filter binding. Reactions (20 ml) contained 25 mM Tris-HCl (pH 7.5), 3
mM MgCl2, 50 mM NaCl, 6.3 mM 2-mercaptoethanol, 100 mg/ml bovine
serum albumin, 12.5% glycerol, and 2.3 mM UvrD or UvrD-R284A (mon-
omer). Binding was initiated by addition of [3H]ATP (1.1 Ci/mmol) to a
final concentration of 200 mM at 0 °C. After 4 min, 15 ml of each reaction
was applied directly to a nitrocellulose filter presoaked in reaction
buffer at 4 °C. Filters were rinsed once with 750 ml of reaction buffer at
a flow rate of 4 ml/min, dried, and subjected to liquid scintillation
counting. Background binding in the absence of enzyme represented
less than 1% of the total signal and was subtracted from the experi-
mental data. The nitrocellulose filters used in the DNA and ATP bind-
ing experiments (0.45 mM type HA, Millipore Corp.) were pre-treated by
soaking in 0.4 M KOH for 40 min followed by extensive washing with
deionized, distilled water.
Glutaraldehyde Cross-linking—The presence of a dimeric helicase II
species was monitored by glutaraldehyde cross-linking as described
previously (27, 49). Reactions (20 ml) contained 20 mM Tricine (pH 8.3),
50 mM NaCl, 5 mM MgCl2, 5 mM 2-mercaptoethanol, 18% glycerol, and
either 1.5 mM UvrD (monomer) or 1.4 mM UvrD-R284A (monomer).
When present, the oligonucleotide (dT)10 and ATPgS were included at a
concentration of 1.7 mM and 3 mM, respectively. Cross-linking was
initiated by the addition of glutaraldehyde (EM grade, Electron Micros-
copy Sciences) to a final concentration of 0.01%. Reactions were incu-
bated at room temperature for 30 min and then quenched with 2 ml of
100 mM lysine acetate and 20 ml of gel-loading buffer (see above).
Samples were boiled for 2 min, and the products were resolved on a
9.6% polyacrylamide gel (32:1 cross-linking ratio) in the presence of
0.1% SDS.
Helicase Assays—The DNA unwinding activity of UvrD and UvrD-
R284A was determined with 92- and 20-bp partial duplex [32P]DNA
substrates prepared as described previously (19, 41). Both substrates
were purified by gel filtration on a Bio-Gel A5M column (Bio-Rad) prior
to use. Helicase reactions (20 ml) contained 25 mM Tris-HCl (pH 7.5), 3
mM MgCl2, 20 mM NaCl, 5 mM 2-mercaptoethanol, 3 mM ATP, and the
indicated partial duplex DNA substrate (approximately 1.3 mM nucleo-
tide phosphate) (1.8 3 108 cpm mmol21 for the 92-bp substrate and 1.6 3
108 cpm mmol21 for the 20-bp substrate). Reactions were pre-warmed at
37 °C and initiated with the indicated amount of UvrD or UvrD-R284A.
After incubation at 37 °C for 10 min, the reactions were quenched with
10 ml of stop solution (37.5% glycerol, 50 mM EDTA, 0.05% each of
xylene cyanol and bromphenol blue, and 0.3% SDS). Products were
resolved on an 8% non-denaturing polyacrylamide gel, and the results
were quantified using phosphor storage technology and ImageQuant
software (Molecular Dynamics).
ATPase Assays—The DNA-stimulated hydrolysis of ATP by UvrD
and UvrD-R284A was measured as described previously (54). ATPase
reaction mixtures were identical to those for the helicase reactions with
the following exceptions. M13mp7 ssDNA (30 mM nucleotide phosphate)
was substituted for the partial duplex helicase substrate, and [3H]ATP
was substituted for unlabeled ATP. Reactions (20 ml) were pre-warmed
at 37 °C and initiated with the indicated amount of [3H]ATP. Reactions
were incubated at 37 °C, and duplicate samples (5 ml) were removed
and quenched with 5 ml of stop solution (33 mM EDTA, 7 mM ATP, and
7 mM ADP) after 5 min for UvrD or 10 min for UvrD-R284A. Products
were processed as described previously (54).
RESULTS
DNA helicase II (also called UvrD) has been included, along
with a large number of other helicases and putative helicases,
in a group designated helicase superfamily I based on conser-
vation of amino acid sequence in seven distinct motifs (13, 15).
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Presumably, these motifs represent sites of functional signifi-
cance that have been evolutionarily conserved. The amino acid
sequences of motif IV from the E. coli superfamily I helicases,
including UvrD, are shown in Fig. 1. To evaluate the functional
significance of motif IV, a mutant uvrD allele was constructed
containing an arginine to alanine substitution at position 284
(uvrD-R284A). This arginine is the most highly conserved res-
idue in motif IV. It is found in all identified members of super-
family I. The ability of the mutant protein to substitute for the
wild-type protein in two DNA repair pathways was examined
in genetic complementation studies. In addition, the UvrD-
R284A protein was purified and biochemically characterized.
Genetic Characterization of UvrD-R284A
DNA helicase II is an essential component of two DNA repair
pathways, methyl-directed mismatch repair and UvrABC-me-
diated nucleotide excision repair (29–31). The ability of UvrD-
R284A to function in each pathway was tested using genetic
complementation assays. The frequency of spontaneous mu-
tant formation in E. coli strain JH137DuvrD was 161-fold
higher than its parent strain JH137 due to loss of a functional
methyl-directed mismatch repair system (55, 56). JH137DuvrD
was also highly sensitive to UV light due to loss of UvrABC-
mediated nucleotide excision repair (57). Plasmids pET9d-
UvrD and pET9d-UvrD-R284A were transformed into
JH137DuvrD to examine the ability of UvrD and UvrD-R284A
to restore the wild-type spontaneous mutant frequency and UV
resistance. The level of uninduced expression of the uvrD gene
from pET9d-UvrD in JH137DuvrD was determined previously
and was only slightly less than expression from the JH137
chromosome (18). This was confirmed in this study (data not
shown).
The frequency of formation of spontaneous mutants at the
rpoB locus (Rifr phenotype) was determined as described under
“Experimental Procedures.” Wild-type uvrD, when introduced
on the pET9d plasmid, fully restored methyl-directed mis-
match repair function as indicated by a relative mutability of
0.6 compared with 1.0 for the parental strain JH137 (Table I).
In contrast, the presence of the uvrD-R284A allele in
JH137DuvrD resulted in a relative mutability of 121, suggest-
ing that the mutant protein did not function in the methyl-
directed mismatch repair pathway.
The ability of UvrD-R284A to function in UvrABC-mediated
nucleotide excision repair was assessed by exposing cells to UV
light and determining survival at increasing UV fluences.
Strains JH137, JH137DuvrD, JH137DuvrD/pET9d,
JH137DuvrD/pET9d-UvrD, and JH137DuvrD/pET9d-UvrD-
R284A were compared as shown in Fig. 2. pET9d-UvrD com-
pletely restored the wild-type level of UV resistance. The mu-
tant allele did not restore wild-type UV resistance and
appeared to make the cells slightly hypersensitive to UV light
as compared with JH137DuvrD. The significance of the latter
observation was not explored. It was clear that UvrD-R284A
was not able to substitute for UvrD in UvrABC-mediated nu-
cleotide excision repair.
Biochemical Characterization of UvrD-R284A
To identify the biochemical defects responsible for the loss of
biological function of UvrD-R284A, mutant and wild-type heli-
case II were purified as described previously (49). UvrD was
purified to apparent homogeneity as evidenced by the presence
of a single protein species on an SDS-polyacrylamide gel (Fig. 3,
lane A). Purified UvrD-R284A was contaminated by three faint
species migrating slightly faster than UvrD-R284A (Fig. 3, lane
D). These species appeared to be proteolytic products of UvrD-
R284A because they all reacted strongly with anti-helicase II
antibody (data not shown). This suggested that the mutant
enzyme was somewhat less stable than the wild-type enzyme.
However, UvrD-R284A folded normally as indicated by a chy-
motrypsin cleavage pattern that was identical to that of UvrD
(Fig. 3, lanes B and E). In the presence of ssDNA, both UvrD-
TABLE I
Spontaneous mutant frequencies of JH137 and JH137 derivatives
The spontaneous mutant frequency was determined as described
under “Experimental Procedures.” Relative mutability was obtained by









JH137 uvrD1 3.0 1
JH137DuvrD DuvrD 485 161
JH137DuvrD/pET9d-UvrD uvrD1 1.8 0.6
JH137DuvrD/pET9d-UvrD-R284A uvrD-R284A 362 121
FIG. 1. The motif structure of superfamily I helicases and the
location of the UvrD-R284A mutation. The approximate positions of
the seven conserved motifs of superfamily I helicases are shown in
UvrD. The amino acid sequences of motif IV of the E. coli members of
this helicase family are also shown along with the sequence of UvrD-
R284A. The alignments of UvrD, Rep, RecB, and RecD are from Hodg-
man (15). TraI and HelD sequences were added to this alignment.
FIG. 2. UV light survival of JH137 and derivatives. E. coli strains
JH137 (l), JH137DuvrD (E), JH137DuvrD/pET9d (f), JH137DuvrD/
pET9d-UvrD (M), and JH137DuvrD/pET9d-UvrD-R284A (å) were ex-
posed to UV light, and survival was calculated as described under
“Experimental Procedures.” The data represent the average of three
independent trials for each strain.
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R284A and UvrD were protected from chymotrypsin cleavage
(Fig. 3, lanes C and F). Furthermore, proteolytic products did
not accumulate with long term enzyme storage. Given these
results and the minimal representation of the smaller species
in the total protein, it was unlikely that their presence influ-
enced the data presented in this study.
DNA Binding—The ability of UvrD-R284A to bind to DNA
was tested using a nitrocellulose filter binding assay and the
92-bp partial duplex helicase substrate. Although the substrate
contains a short duplex region, the assay measured primarily
the affinity of the protein for ssDNA due to the lack of signif-
icant binding of helicase II to double-stranded DNA. DNA
binding isotherms were generated using a constant ligand con-
centration and varying concentrations of helicase II (Fig. 4). A
Hill plot was used to calculate apparent equilibrium dissocia-
tion constants from these data as described previously (27, 53).
There was no significant difference between the DNA binding
properties of UvrD-R284A and UvrD (apparent Kd of 11 and 17
nM, respectively). Thus, the highly conserved arginine residue
in motif IV was not required for nucleic acid binding. This
conclusion was further supported by the results of limited
proteolysis experiments (see Fig. 3), which demonstrated that
both UvrD and UvrD-R284A were protected from chymotrypsin
cleavage when an ssDNA ligand was present and presumably
bound by the enzyme.
Dimerization—A glutaraldehyde cross-linking procedure
was used to detect dimerization of UvrD and UvrD-R284A (49).
Glutaraldehyde catalyzes the formation of a covalent bond
between primary amines in close proximity, providing a simple
method for detecting protein-protein interactions in solution.
UvrD and UvrD-R284A, at a relatively high concentration,
were each exposed to a low concentration of glutaraldehyde in
the absence or presence of ATPgS or oligonucleotide (dT)10. The
products were resolved on an SDS-polyacrylamide gel and
stained with Coomassie Blue. No difference in the dimerization
of UvrD and UvrD-R284A was observed in the absence or
presence of ATPgS or oligo(dT)10 (data not shown).
ATP Hydrolysis—Helicase II catalyzes a DNA-stimulated
ATP hydrolysis reaction that is coupled to the unwinding re-
action. To begin to evaluate the ATPase activity of UvrD-
R284A, we attempted to measure a Km for ATP. Wild-type
UvrD exhibited a standard hyperbolic saturation curve as a
function of increasing ATP concentration with a Km of 80 6 7
mM (Fig. 5A). The Km value of UvrD-R284A for ATP was too
high to be determined because the maximal velocity could not
be approached. The velocity of ATP hydrolysis catalyzed by
UvrD-R284A was a linear function of ATP concentration up to
3 mM (Fig. 5B). Apparent substrate inhibition of the wild-type
enzyme prevented accurate measurement of ATP hydrolysis
velocities at substantially higher ATP concentrations (data not
shown). The inability to saturate UvrD-R284A with ATP sug-
gested that it was defective in nucleotide binding.
ATP Binding—To directly measure the affinity of helicase II
for ATP, an initial attempt was made to determine the equi-
librium dissociation constant, Kd. Several techniques were
used without success, including fluorescence spectroscopy and
nitrocellulose filter binding. Failure to determine a Kd was the
result of the limited solubility of helicase II and its relatively
low affinity for ATP, which made it impossible to generate a
complete and reproducible binding curve using these assays. In
addition, we did not observe an intrinsic fluorescence change in
helicase II upon ATP binding. However, having a Kd for the
UvrD-ATP interaction would not be useful for comparative
purposes if we were unable to measure this value for UvrD-
R284A. Instead, nitrocellulose filter binding assays were used
as a qualitative comparison of ATP binding between UvrD and
UvrD-R284A by measuring the amount of [3H]ATP bound at a
single nucleotide concentration. These assays were performed
at 0 °C and in the absence of DNA. Under these conditions, the
turnover number for wild-type helicase II was approximately
0.002 s21 (data not shown). Table II shows that at 200 mM
[3H]ATP, UvrD bound 0.92 pmol of ATP/pmol of enzyme. This
fraction of ATP-bound enzyme was fairly consistent with a Km
of 80 mM ATP. In contrast, UvrD-R284A bound only 0.015 pmol
of ATP/pmol of enzyme, 1.6% of the wild-type value. These
FIG. 3. a-Chymotrypsin digestion of UvrD and UvrD-R284A.
UvrD and UvrD-R284A were subjected to limited proteolytic digestion
by a-chymotrypsin as described under “Experimental Procedures.”
Lanes A and D, purified UvrD and UvrD-R284A, respectively; lanes B
and E, the products of the UvrD and UvrD-R284A proteolysis reactions,
respectively; lanes C and F, 2 mM M13mp7 ssDNA was added to the
UvrD and UvrD-R284A proteolysis reactions. The UvrD concentration
was 2 mM (monomer), and the UvrD-R284A concentration was 1.8 mM
(monomer). The molecular mass standards were: rabbit muscle phos-
phorylase b (97.4 kDa), bovine serum albumin (66.2 kDa), hen egg white
ovalbumin (45.0 kDa), bovine carbonic anhydrase (31.0 kDa), and soy-
bean trypsin inhibitor (21.5 kDa). FIG. 4. DNA binding by UvrD and UvrD-R284A. Nitrocellulose
filter binding assays were used to evaluate DNA binding as described
under “Experimental Procedures” using UvrD (l) or UvrD-R284A (f).
Data represent the average of at least three independent trials, and
error bars are the standard deviations.
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results suggested that UvrD-R284A was defective in its asso-
ciation with ATP.
Helicase Activity—The lack of genetic complementation in
both DNA repair pathways suggested that the mutant protein
was severely compromised in its DNA unwinding activity. The
unwinding activity of UvrD-R284A was measured using two
short partial duplex DNA substrates and was compared with
UvrD (Fig. 6). The mutant enzyme failed to catalyze unwinding
of a 92-bp duplex region and catalyzed feeble unwinding of a
20-bp duplex region in a 10-min incubation. At a UvrD-R284A
concentration of 344 nM, there was no detectable unwinding of
the 92-bp partial duplex substrate and less than 10 percent
unwinding of the 20-bp partial duplex substrate. In contrast,
wild-type helicase II unwound 50% of the 92-bp partial duplex
substrate at a protein concentration of 25 nM and 50% of the
20-bp partial duplex substrate at a protein concentration of 0.5
nM. In a 100-min incubation, 197 nM UvrD-R284A unwound
39% of the 20-bp partial duplex. Under the same conditions,
344 nM mutant enzyme did not unwind a detectable fraction of
the 92-bp substrate (data not shown).
DISCUSSION
The results presented here indicate that arginine 284 is
required for high affinity binding of ATP, which suggests that
motif IV is an integral part of the nucleotide binding site on
DNA helicase II. This was initially surprising since it is gen-
erally believed that helicase motifs I and II are involved in NTP
binding and/or hydrolysis. This notion stems from the fact that
motifs I and II are common to a large population of NTP-
binding proteins, including the DNA helicases (17). Moreover,
biochemical studies on mutants of a wide range of helicases
have generally supported a role for motifs I and II in NTP
hydrolysis (18–22). Most of the mutations, however, did not
affect NTP binding. Helicase motif IV is not conserved among
all NTP binding proteins, which suggested that it might be
important for a biochemical property common to helicases.
However, UvrD-R284A exhibited a significant defect in ATP
binding, and in light of the recent crystal structure of PcrA, this
result can be readily explained (see below).
Efforts to define the kinetic parameters Km and kcat for the
DNA-stimulated ATP hydrolysis reaction revealed an inability
to saturate UvrD-R284A with ATP. Since the ATPase reaction
velocity was a linear function of ATP concentration up to 3 mM,
the Km for ATP must be much greater than 3 mM. Km is defined
as the concentration of substrate that provides half-maximal
reaction velocity. If it is assumed that the ATPase reaction
catalyzed by helicase II can be described by simple Michaelis-
Menten kinetics and that a minimal reaction is represented by







then Km is equal to (k-1 1 k2)/k1. If k2 is small compared with
the dissociation rate constant k-1, then Km is equal to the
equilibrium dissociation constant, Kd (k-1/k1). However, if k2 is
comparable with k-1, then ES is not in equilibrium with E 1 S,
and Km is not equal to Kd. Furthermore, Km does not approxi-
mate Kd if multiple enzyme-bound intermediates are on the
reaction pathway. In the case where multiple intermediates
exist, Km reflects an overall dissociation constant for all of the
enzyme-bound species (58). Because the kinetic mechanism for
ATP hydrolysis catalyzed by helicase II is not known, it was not
possible to unequivocally conclude that the large increase in
the Km value of UvrD-R284A was the direct result of a de-
creased affinity for ATP. For example, a decrease in the rate of
product release or changes in rate constants associated with
conformational changes could also affect Km. In fact, it is pos-
sible to envision a kinetic mechanism in which an increase in
FIG. 5. ATP hydrolysis by UvrD and
UvrD-R284A. ATP hydrolysis was meas-
ured as described under “Experimental
Procedures” for UvrD (panel A) and
UvrD-R284A (panel B). Reactions con-
taining 2.1 nM UvrD or 229 nM UvrD-
R284A (monomer) were initiated with the
indicated concentration of [3H]ATP and
incubated at 37 °C for 5 min (UvrD) or 10
min (UvrD-R284A). SigmaPlot (Jandel
Scientific) was used to fit the data for
UvrD in panel A to a standard rectangu-
lar hyperbola and to generate the linear
regression for UvrD-R284A in panel B.
The inset in panel A represents an Eadie-
Hofstee plot of the data shown in panel A.
Km was calculated from the Eadie-Hofstee
plot. The data in both panels A and B are
averages obtained from at least three in-
dependent experiments with error bars
representing standard deviations.
TABLE II
ATP binding by UvrD and UvrD-R284A
ATP binding was measured by a nitrocellulose filter assay as de-
scribed under “Experimental Procedures.” UvrD and UvrD-R284A were
2.3 mM (monomer) and [3H]ATP was 200 mM in the reactions. Data
represent the average of eight independent trials.
Enzyme pmol bound perpmol of enzyme
UvrD 0.92
UvrD-R284A 0.015
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Km is not related to ATP binding but, rather, is solely the result
of a decrease in the rate of hydrolysis. Such a mechanism is
very unlikely for helicase II, however, because several UvrD
mutants have been characterized that exhibited a significant
decrease in the kcat for ATP hydrolysis without affecting Km
(18, 19, 44).
To isolate and evaluate the initial ATP binding event, con-
ditions were sought under which a negligible amount of ATP
hydrolysis occurred. At 0 °C in the absence of DNA, the turn-
over number for ATP by UvrD was approximately 0.002 s21. No
hydrolysis was detected under these conditions using UvrD-
R284A. Thus, the nitrocellulose filter binding assay likely
measured only E 1 S i ES, again assuming the simple
Michaelis-Menten scheme depicted above. Since the amount of
ATP bound by UvrD-R284A was significantly decreased under
these conditions, a decreased affinity for ATP was likely the
primary defect in the mutant protein. Thus, the large increase
in Km for ATP was the result of a decreased affinity for the
substrate.
A defect in ATP binding would seem to be at odds with the
results of proteolysis protection experiments (data not shown).
The presence of ATP, like ssDNA, protects wild-type helicase II
from cleavage by chymotrypsin (51). Based on the decreased
binding of ATP by UvrD-R284A, we expected to see a large
difference in the amount of ATP required to protect UvrD
versus UvrD-R284A from proteolytic cleavage. In fact, the in-
crease in the concentration of ATP required for protection of
UvrD-R284A compared with UvrD was relatively small (less
than 2-fold, data not shown). However, the structural changes
responsible for proteolysis protection when ligands are present
are not known. This fact, coupled with the lack of information
on the kinetic mechanism for ATP hydrolysis catalyzed by
helicase II, makes it possible that the proteolysis protection
assay does not directly measure ATP binding. For example, an
ATP concentration of 1.5–2.0 mM was required for significant
protection of UvrD from cleavage by chymotrypsin. This is
clearly inconsistent with a Km for ATP of 80 mM. This fact alone
indicates that this assay measures something more complex
than simple ATP binding. Furthermore, when the poorly hy-
drolyzed ATP analog ATPgS was used as a ligand, there was a
more substantial increase in the concentration required for
proteolytic protection of UvrD-R284A compared with UvrD
(approximately 6-fold, data not shown). The results of the pro-
teolysis protection study likely reflected a combination of pro-
cesses such as ATP hydrolysis and conformational changes in
the protein, in addition to nucleotide binding. Thus, the results
of this series of experiments, while not fully explained, cannot
be interpreted as evidence for a normal interaction with ATP.
Although there was clearly a serious defect in nucleotide
binding, it was also possible that an additional defect existed in
the hydrolytic mechanism. Such a defect would also have con-
tributed to the inability of UvrD-R284A to unwind DNA and
function in DNA repair pathways. It was possible to estimate a
Km for UvrD-R284A from the data in Fig. 5 if we assumed the
hydrolytic mechanism was unaffected. The initial slope of a
reaction velocity versus substrate concentration graph, such as
the one depicted in Fig. 5, is equal to kcat/Km 3 ET, where ET is
the total enzyme concentration. If the hydrolytic mechanism of
UvrD-R284A were unaffected by the mutation, then kcat should
have been equal to that of UvrD. From the slope of the line in
Fig. 5B and the UvrD kcat of 162 s
21, an estimated Km for ATP
for UvrD-R284A was 143 mM. The plot of initial velocity versus
substrate concentration for UvrD-R284A was linear to at least
3 mM ATP. Since there was no deviation from linearity, it was
concluded that the actual Km was significantly higher than 3
mM. Apparent substrate inhibition with wild-type helicase II at
high ATP concentrations, coupled with the necessary modifica-
tions in reaction conditions, made it impossible to accurately
measure hydrolysis at ATP concentrations significantly higher
than 3 mM. Therefore, the relationship between the apparent
Km for ATP and the 143 mM value estimated above was not
determined. In light of these results, it remains possible that
there was a defect in the hydrolytic mechanism of UvrD-R284A
in addition to the severe defect in ATP binding.
The helicase activity of the UvrD-R284A mutant was signif-
icantly compromised, and the protein failed to function in vivo.
Helicase activity is dependent on ATP hydrolysis, and it
seemed reasonable to conclude that the lack of unwinding was
FIG. 6. Helicase activity of UvrD
and UvrD-R284A. The unwinding of
92-bp (panel A) and 20-bp (panel B) par-
tial duplex DNA substrates by UvrD (l)
and UvrD-R284A (f) was measured as
described under “Experimental Proce-
dures.” Data represent the average of at
least three independent experiments, and
error bars are standard deviations.
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due to the tremendous decrease in ATP hydrolysis that, in
turn, was due to a decreased affinity of the mutant enzyme for
ATP. However, the possibility that the R284A substitution also
directly impaired the unwinding mechanism or the coupling
between hydrolysis and unwinding cannot formally be ruled
out. Based on the results presented here, the lack of biological
function in both DNA repair pathways was probably a result of
the ATP binding defect. With a Km for ATP significantly
greater than 3 mM, it is unlikely that an intracellular ATP
concentration of 3 mM (59) would be sufficient to adequately
populate the active helicase II pool and allow the enzyme to
function properly in vivo.
To the best of our knowledge, UvrD-R284A represents the
first helicase mutant, outside of motifs I and II, whose primary
defect is in nucleotide binding. A helicase II mutant in motif III
was defective in binding ATP but only in the absence of ssDNA
(27). This mutant was also defective in binding ssDNA in the
absence of ATP. In the presence of ssDNA, the motif III mutant
bound ATP with normal affinity, and it was concluded that the
motif III mutant was compromised in the ability to form stable
binary complexes with its two ligands.
The ATP binding defect described in this study is consistent
with the recently published crystal structure of the PcrA heli-
case (28). The overall amino acid sequence of the PcrA helicase
from B. stearothermophilus is 44% identical to UvrD and 90%
identical within the seven conserved helicase motifs. Notably,
these seven motifs are clustered together at the base of the
enzyme, forming the ATP-binding pocket. In view of the exten-
sive amino acid identity, particularly among the conserved
motifs, it is likely that the structure of the nucleotide binding
sites of PcrA and UvrD closely resemble one another. From this
structure, it seems likely that all seven motifs may be involved
in nucleotide binding and/or hydrolysis, and thus, a role for
motif IV in ATP binding is not surprising.
The PcrA structure indicates that motif IV forms a bridge
connecting the two large domains of the protein at the bottom
of the nucleotide binding pocket. This region lies near the
adenine base of the bound nucleotide, and the authors suggest
that a conserved tyrosine in motif IV makes a stacking inter-
action with the bound NTP. This tyrosine, which is not con-
served in all superfamily I helicases, is immediately followed
by the invariant arginine that was altered in this study (see
Fig. 1). The apparent absence of additional specific interactions
between the adenine base and nearby amino acid residues was
suggested as an explanation for the lack of nucleotide specific-
ity in reactions catalyzed by the PcrA helicase. UvrD, on the
other hand, exhibits a strong preference for ATP or dATP (60),
and it is possible that arginine 284 is involved in a specific
interaction with the adenine base on ATP and dATP, whereas
its counterpart in PcrA contributes less to specificity. Alterna-
tively, arginine 284 may not directly contact the nucleotide but
might mediate a local conformational change that places other
residues, such as tyrosine 283, in proper position to interact
with the NTP. Yet another possibility is that motif IV, acting as
a bridge between the two large domains of the helicase, might
mediate a global conformational change in the protein that is
required for high affinity NTP binding. A more detailed de-
scription of the role of arginine 284 in ATP binding must await
a high resolution structure for ATP-bound helicase II.
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